Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.770
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
1.780
+0.010 (0.56%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Microbot Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Microbot Medical stock have an average target of 6.63, with a low estimate of 4.00 and a high estimate of 12. The average target predicts an increase of 274.58% from the current stock price of 1.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Microbot Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Lucid Capital No rating | Lucid Capital | Buy Initiates $4 | Buy | Initiates | $4 | +125.99% | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +577.97% | Apr 14, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $5.5 | Buy | Reiterates | $5.5 | +210.73% | Apr 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $5 | Buy | Initiates | $5 | +182.49% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
3.45M
Revenue Next Year
10.60M
from 3.45M
Increased by 207.25%
EPS This Year
-0.30
from -0.29
EPS Next Year
-0.32
from -0.30
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5M | 11.0M | |
| Avg | 3.5M | 10.6M | |
| Low | 3.4M | 10.2M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 218.8% | 153.8% |
| Avg | 207.2% | 126.4% |
| Low | 195.7% | 99.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.30 | -0.32 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.